Published in Epidemiology on January 01, 2010
Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med (2010) 14.49
Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. N Engl J Med (2013) 7.40
Prognostic indices for older adults: a systematic review. JAMA (2012) 5.70
Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease. PLoS Genet (2011) 5.01
A combined comorbidity score predicted mortality in elderly patients better than existing scores. J Clin Epidemiol (2011) 3.98
Lipid-related markers and cardiovascular disease prediction. JAMA (2012) 3.91
Perioperative comparative effectiveness of anesthetic technique in orthopedic patients. Anesthesiology (2013) 3.45
Prognosis Research Strategy (PROGRESS) 3: prognostic model research. PLoS Med (2013) 3.13
A multibiomarker-based outcome risk stratification model for adult septic shock*. Crit Care Med (2014) 2.94
Prediction models for cardiovascular disease risk in the general population: systematic review. BMJ (2016) 2.81
A scoring system to predict unplanned intubation in patients having undergone major surgical procedures. Anesth Analg (2012) 2.67
Development and evaluation of the universal ACS NSQIP surgical risk calculator: a decision aid and informed consent tool for patients and surgeons. J Am Coll Surg (2013) 2.37
The utility of nodule volume in the context of malignancy prediction for small pulmonary nodules. Chest (2014) 2.30
One statistical test is sufficient for assessing new predictive markers. BMC Med Res Methodol (2011) 2.24
Predicting outcomes in radiation oncology--multifactorial decision support systems. Nat Rev Clin Oncol (2012) 2.23
The relationship between the C-statistic of a risk-adjustment model and the accuracy of hospital report cards: a Monte Carlo Study. Med Care (2013) 2.20
Graphical assessment of internal and external calibration of logistic regression models by using loess smoothers. Stat Med (2013) 2.13
External validity of risk models: Use of benchmark values to disentangle a case-mix effect from incorrect coefficients. Am J Epidemiol (2010) 2.03
Multicenter validation of urinary CXCL9 as a risk-stratifying biomarker for kidney transplant injury. Am J Transplant (2013) 1.99
Random forests for genomic data analysis. Genomics (2012) 1.98
The New American Joint Committee on Cancer/International Union Against Cancer staging system for adenocarcinoma of the stomach: increased complexity without clear improvement in predictive accuracy. Ann Surg Oncol (2012) 1.87
Problems with risk reclassification methods for evaluating prediction models. Am J Epidemiol (2011) 1.84
Assessing improvement in disease prediction using net reclassification improvement: impact of risk cut-offs and number of risk categories. Eur J Epidemiol (2012) 1.75
PredictABEL: an R package for the assessment of risk prediction models. Eur J Epidemiol (2011) 1.73
Interpreting the concordance statistic of a logistic regression model: relation to the variance and odds ratio of a continuous explanatory variable. BMC Med Res Methodol (2012) 1.71
Prospective study of serum adiponectin and incident metabolic syndrome: the ARIRANG study. Diabetes Care (2012) 1.71
Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis. Am J Cardiol (2012) 1.69
Performance of reclassification statistics in comparing risk prediction models. Biom J (2011) 1.63
Clinical Prediction Models for Cardiovascular Disease: Tufts Predictive Analytics and Comparative Effectiveness Clinical Prediction Model Database. Circ Cardiovasc Qual Outcomes (2015) 1.62
Dynamic trends in cardiac surgery: why the logistic EuroSCORE is no longer suitable for contemporary cardiac surgery and implications for future risk models. Eur J Cardiothorac Surg (2012) 1.62
External validation of multivariable prediction models: a systematic review of methodological conduct and reporting. BMC Med Res Methodol (2014) 1.57
The added value of percentage of free to total prostate-specific antigen, PCA3, and a kallikrein panel to the ERSPC risk calculator for prostate cancer in prescreened men. Eur Urol (2014) 1.57
Prediction models for risk of developing type 2 diabetes: systematic literature search and independent external validation study. BMJ (2012) 1.52
Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer. Clin Cancer Res (2012) 1.51
Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study. BMJ (2010) 1.50
Predicting early mortality in adult trauma patients admitted to three public university hospitals in urban India: a prospective multicentre cohort study. PLoS One (2014) 1.49
Assessment of potential bias from non-participation in a dynamic clinical cohort of long-term childhood cancer survivors: results from the St. Jude Lifetime Cohort Study. Pediatr Blood Cancer (2012) 1.49
A Multibiomarker-Based Model for Estimating the Risk of Septic Acute Kidney Injury. Crit Care Med (2015) 1.49
Short-term mortality prediction for acute lung injury patients: external validation of the Acute Respiratory Distress Syndrome Network prediction model. Crit Care Med (2011) 1.48
Troponin T, N-terminal pro-B-type natriuretic peptide, and incidence of stroke: the atherosclerosis risk in communities study. Stroke (2013) 1.47
Assessing the incremental value of diagnostic and prognostic markers: a review and illustration. Eur J Clin Invest (2011) 1.46
Do claims-based comorbidities adequately capture case mix for surgical site infections? Clin Orthop Relat Res (2014) 1.45
Towards better clinical prediction models: seven steps for development and an ABCD for validation. Eur Heart J (2014) 1.44
Predicting non return to work after orthopaedic trauma: the Wallis Occupational Rehabilitation RisK (WORRK) model. PLoS One (2014) 1.42
Towards improving diagnosis of memory loss in general practice: TIMeLi diagnostic test accuracy study protocol. BMC Fam Pract (2016) 1.40
A clinical prediction model to identify patients at high risk of death in the emergency department. Intensive Care Med (2015) 1.40
Strong predictive value of mannose-binding lectin levels for cardiovascular risk of hemodialysis patients. J Transl Med (2016) 1.40
Machine learning algorithms outperform conventional regression models in predicting development of hepatocellular carcinoma. Am J Gastroenterol (2013) 1.39
Development and Validation of a Clinical Prediction Rule for Bacteremia among Maintenance Hemodialysis Patients in Outpatient Settings. PLoS One (2017) 1.39
Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis. PLoS One (2017) 1.39
Assessment of predictive performance in incomplete data by combining internal validation and multiple imputation. BMC Med Res Methodol (2016) 1.39
Can screening instruments accurately determine poor outcome risk in adults with recent onset low back pain? A systematic review and meta-analysis. BMC Med (2017) 1.38
Real-time individual predictions of prostate cancer recurrence using joint models. Biometrics (2013) 1.38
Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist. PLoS Med (2014) 1.35
Sample size considerations for the external validation of a multivariable prognostic model: a resampling study. Stat Med (2015) 1.35
Regression trees for predicting mortality in patients with cardiovascular disease: what improvement is achieved by using ensemble-based methods? Biom J (2012) 1.28
Testing the prognostic accuracy of the updated pediatric sepsis biomarker risk model. PLoS One (2014) 1.22
A clinical risk prediction model for Barrett esophagus. Cancer Prev Res (Phila) (2012) 1.21
Prognostic models for stable coronary artery disease based on electronic health record cohort of 102 023 patients. Eur Heart J (2013) 1.18
Letter to the editor concerning 'Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis'. Ann Oncol (2015) 1.17
Interferon release does not add discriminatory value to smear-negative HIV-tuberculosis algorithms. Eur Respir J (2011) 1.13
Evaluation of markers and risk prediction models: overview of relationships between NRI and decision-analytic measures. Med Decis Making (2013) 1.13
Statistical consideration for clinical biomarker research in bladder cancer. Urol Oncol (2010) 1.12
Predicting risk of type 2 diabetes mellitus with genetic risk models on the basis of established genome-wide association markers: a systematic review. Am J Epidemiol (2013) 1.11
Translating biomarkers to clinical practice. Mol Psychiatry (2011) 1.09
Updating risk prediction tools: a case study in prostate cancer. Biom J (2011) 1.08
International Validity of the HOSPITAL Score to Predict 30-Day Potentially Avoidable Hospital Readmissions. JAMA Intern Med (2016) 1.08
Development of a scoring system to predict massive postpartum transfusion in placenta previa totalis. J Anesth (2017) 1.08
A framework for quantifying net benefits of alternative prognostic models. Stat Med (2011) 1.08
Role of ST2 in non-ST-elevation acute coronary syndrome in the MERLIN-TIMI 36 trial. Clin Chem (2011) 1.07
Everything you always wanted to know about evaluating prediction models (but were too afraid to ask). Urology (2010) 1.06
Improving cell mixture deconvolution by identifying optimal DNA methylation libraries (IDOL). BMC Bioinformatics (2016) 1.06
A mathematical model for interpretable clinical decision support with applications in gynecology. PLoS One (2012) 1.05
Simplified prognostic model in patients with oxaliplatin-based or irinotecan-based first-line chemotherapy for metastatic colorectal cancer: a GERCOR study. Oncologist (2011) 1.05
External validation of the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer risk calculators in a Chinese cohort. Asian J Androl (2012) 1.05
Development and validation of a risk score for serious infection in patients with rheumatoid arthritis. Arthritis Rheum (2012) 1.03
Development and validation of a predicting model of all-cause mortality in patients with type 2 diabetes. Diabetes Care (2013) 1.03
STRengthening analytical thinking for observational studies: the STRATOS initiative. Stat Med (2014) 1.01
Classical and novel biomarkers for cardiovascular risk prediction in the United States. J Epidemiol (2013) 1.00
Comparison between various fracture risk assessment tools. Osteoporos Int (2014) 1.00
Assessing calibration of prognostic risk scores. Stat Methods Med Res (2013) 1.00
Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group. World J Urol (2011) 1.00
Validation of the multivariable In-hospital Mortality for PulmonAry embolism using Claims daTa (IMPACT) prediction rule within an all-payer inpatient administrative claims database. BMJ Open (2015) 1.00
Polytomous diagnosis of ovarian tumors as benign, borderline, primary invasive or metastatic: development and validation of standard and kernel-based risk prediction models. BMC Med Res Methodol (2010) 0.99
Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-31). Diabetes Care (2013) 0.99
Assessing the discriminative ability of risk models for more than two outcome categories. Eur J Epidemiol (2012) 0.98
Cardiovascular Disease Risk Assessment: Insights from Framingham. Glob Heart (2013) 0.98
Development and validation of a predictive model for detection of colorectal cancer in primary care by analysis of complete blood counts: a binational retrospective study. J Am Med Inform Assoc (2016) 0.96
Diagnostic performance of the ACR/EULAR 2010 criteria for rheumatoid arthritis and two diagnostic algorithms in an early arthritis clinic (REACH). Ann Rheum Dis (2011) 0.96
Decision curve analysis revisited: overall net benefit, relationships to ROC curve analysis, and application to case-control studies. BMC Med Inform Decis Mak (2011) 0.95
An evaluation of POSSUM and P-POSSUM scoring in predicting post-operative mortality in a level 1 critical care setting. BMC Anesthesiol (2014) 0.95
Novel methods to evaluate fracture risk models. J Bone Miner Res (2011) 0.95
Derivation and assessment of risk prediction models using case-cohort data. BMC Med Res Methodol (2013) 0.95
Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. Eur J Epidemiol (2011) 0.94
How to develop a more accurate risk prediction model when there are few events. BMJ (2015) 0.94
Performance of matrix-based risk models for rapid radiographic progression in a cohort of patients with established rheumatoid arthritis. Arthritis Care Res (Hoboken) (2013) 0.94
Assessing the importance of predictors in unplanned hospital readmissions for chronic obstructive pulmonary disease. Clinicoecon Outcomes Res (2015) 0.94
Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med (2008) 57.29
Index for rating diagnostic tests. Cancer (1950) 27.09
Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation (2007) 20.44
Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol (2004) 12.03
Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making (2006) 11.83
Why most discovered true associations are inflated. Epidemiology (2008) 11.22
Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol (2001) 10.16
What do we mean by validating a prognostic model? Stat Med (2000) 9.18
The threshold approach to clinical decision making. N Engl J Med (1980) 8.51
A comparison of goodness-of-fit tests for the logistic regression model. Stat Med (1997) 8.51
Assessing the generalizability of prognostic information. Ann Intern Med (1999) 8.04
Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures. Ann Intern Med (2009) 7.62
Survival model predictive accuracy and ROC curves. Biometrics (2005) 7.26
Primer on certain elements of medical decision making. N Engl J Med (1975) 6.28
On criteria for evaluating models of absolute risk. Biostatistics (2005) 5.71
Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve. Clin Chem (2007) 5.23
Translating clinical research into clinical practice: impact of using prediction rules to make decisions. Ann Intern Med (2006) 5.17
Assessing the value of risk predictions by using risk stratification tables. Ann Intern Med (2008) 5.05
Integrating the predictiveness of a marker with its performance as a classifier. Am J Epidemiol (2007) 4.59
Receiver operating characteristic curves and their use in radiology. Radiology (2003) 4.57
The numerical measure of the success of predictions. Science (1884) 3.33
Validation and updating of predictive logistic regression models: a study on sample size and shrinkage. Stat Med (2004) 2.95
Estimation of time-dependent area under the ROC curve for long-term risk prediction. Stat Med (2006) 2.86
Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements. J Clin Epidemiol (2004) 2.77
The toss-up. N Engl J Med (1981) 2.71
Consistent estimation of the expected Brier score in general survival models with right-censored event times. Biom J (2006) 2.55
A review and critique of some models used in competing risk analysis. Biometrics (1975) 2.44
Predictive value of statistical models. Stat Med (1990) 2.36
Assessing new biomarkers and predictive models for use in clinical practice: a clinician's guide. Arch Intern Med (2008) 2.35
Validity of prognostic models: when is a model clinically useful? Semin Urol Oncol (2002) 2.29
Judging new markers by their ability to improve predictive accuracy. J Natl Cancer Inst (2003) 2.11
The performance of risk prediction models. Biom J (2008) 2.00
Decision curve analysis: a discussion. Med Decis Making (2008) 1.87
Assessment of survival prediction models based on microarray data. Bioinformatics (2007) 1.79
Properties of R(2) statistics for logistic regression. Stat Med (2006) 1.76
Letter by Pepe et al regarding article, "Use and misuse of the receiver operating characteristic curve in risk prediction". Circulation (2007) 1.71
Resection of small, residual retroperitoneal masses after chemotherapy for nonseminomatous testicular cancer: a decision analysis. Cancer (1999) 1.71
Randomized controlled trials with time-to-event outcomes: how much does prespecified covariate adjustment increase power? Ann Epidemiol (2005) 1.61
Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups. J Clin Oncol (1995) 1.60
Actual and actuarial probabilities of competing risks: apples and lemons. Ann Thorac Surg (2007) 1.43
A checklist for evaluating reports of expression profiling for treatment selection. Clin Adv Hematol Oncol (2006) 1.38
External validation of prognostic models for critically ill patients required substantial sample sizes. J Clin Epidemiol (2007) 1.36
Validation of probabilistic predictions. Med Decis Making (1993) 1.33
Selecting patients for randomized trials: a systematic approach based on risk group. Trials (2006) 1.33
Two new prediction rules for spontaneous pregnancy leading to live birth among subfertile couples, based on the synthesis of three previous models. Hum Reprod (2004) 1.29
The area under the ROC curve and its competitors. Med Decis Making (1991) 1.19
Validation of a prediction model and its predictors for the histology of residual masses in nonseminomatous testicular cancer. J Urol (2001) 1.17
How to assess prognostic models for survival data: a case study in oncology. Methods Inf Med (2003) 1.12
Statistical methods in diagnosis. Stat Methods Med Res (1992) 1.11
The measurement of performance in probabilistic diagnosis. II. Trustworthiness of the exact values of the diagnostic probabilities. Methods Inf Med (1978) 1.03
The measurement of performance in probabilistic diagnosis. IV. Utility considerations in therapeutics and prognostics. Methods Inf Med (1981) 1.01
Residual mass histology in testicular cancer: development and validation of a clinical prediction rule. Stat Med (2001) 1.00
General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation (2008) 26.42
A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med (2005) 17.32
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med (2002) 16.23
Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA (2007) 15.32
Vitamin D deficiency and risk of cardiovascular disease. Circulation (2008) 13.39
Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA (2005) 12.09
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med (2015) 9.70
Statins: new American guidelines for prevention of cardiovascular disease. Lancet (2013) 9.56
Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation (2010) 9.09
Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol (2006) 8.61
Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg (2002) 8.30
C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation (2008) 7.33
Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet (2009) 7.27
Variations in morbidity after radical prostatectomy. N Engl J Med (2002) 7.26
C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation (2003) 6.99
Diagnostic accuracy of fractional flow reserve from anatomic CT angiography. JAMA (2012) 6.96
Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. JAMA (2007) 6.95
Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer. J Clin Oncol (2003) 6.93
Migraine and risk of cardiovascular disease in women. JAMA (2006) 6.16
The surgical learning curve for prostate cancer control after radical prostatectomy. J Natl Cancer Inst (2007) 6.12
Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3. Ann Intern Med (2009) 6.00
Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med (2011) 5.94
Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA (2005) 5.74
One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA (2007) 5.61
Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia. Sci Transl Med (2014) 5.60
Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA (2009) 5.52
Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol (2007) 5.24
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol (2007) 5.23
Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer. Cancer (2010) 5.22
A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol (2003) 5.20
Variations in lung cancer risk among smokers. J Natl Cancer Inst (2003) 5.00
Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol (2007) 4.95
Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol (2005) 4.89
Association of smoking cessation and weight change with cardiovascular disease among adults with and without diabetes. JAMA (2013) 4.81
Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial. J Natl Cancer Inst (2007) 4.64
Relations of thyroid function to body weight: cross-sectional and longitudinal observations in a community-based sample. Arch Intern Med (2008) 4.63
A risk score for predicting near-term incidence of hypertension: the Framingham Heart Study. Ann Intern Med (2008) 4.61
Pharmacogenetic study of statin therapy and cholesterol reduction. JAMA (2004) 4.47
Association between a literature-based genetic risk score and cardiovascular events in women. JAMA (2010) 4.46
Rationale, design, and methodology of the Women's Genome Health Study: a genome-wide association study of more than 25,000 initially healthy american women. Clin Chem (2007) 4.45
On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data. Stat Med (2011) 4.34
Loci related to metabolic-syndrome pathways including LEPR,HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study. Am J Hum Genet (2008) 4.31
Prostate-specific antigen and prostate cancer: prediction, detection and monitoring. Nat Rev Cancer (2008) 4.15
Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Natl Cancer Inst (2006) 4.14
Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. JAMA (2004) 4.10
Empirical study of data sharing by authors publishing in PLoS journals. PLoS One (2009) 4.09
Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition. J Clin Oncol (2006) 4.05
Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis. Am J Surg Pathol (2005) 3.99
Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study. Circulation (2007) 3.99
Effects of pathologic stage on the learning curve for radical prostatectomy: evidence that recurrence in organ-confined cancer is largely related to inadequate surgical technique. Eur Urol (2008) 3.93
Nomogram for overall survival of patients with progressive metastatic prostate cancer after castration. J Clin Oncol (2002) 3.93
Randomized phase II trial of cetuximab, bevacizumab, and irinotecan compared with cetuximab and bevacizumab alone in irinotecan-refractory colorectal cancer: the BOND-2 study. J Clin Oncol (2007) 3.85
Childhood blood pressure trends and risk factors for high blood pressure: the NHANES experience 1988-2008. Hypertension (2013) 3.81
Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era. J Clin Oncol (2009) 3.74
Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years. J Clin Oncol (2007) 3.72
Needle biopsies on autopsy prostates: sensitivity of cancer detection based on true prevalence. J Natl Cancer Inst (2007) 3.70
Against diagnosis. Ann Intern Med (2008) 3.69
Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol (2002) 3.61
Decision making in advanced heart failure: a scientific statement from the American Heart Association. Circulation (2012) 3.61
Long-term trends in the incidence of heart failure after myocardial infarction. Circulation (2008) 3.52
Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer. J Clin Oncol (2006) 3.46
Mortality after prostate cancer treatment with radical prostatectomy, external-beam radiation therapy, or brachytherapy in men without comorbidity. Eur Urol (2013) 3.41
Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart Study. Circulation (2006) 3.41
Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies. Cell (2012) 3.39
Preparing raw clinical data for publication: guidance for journal editors, authors, and peer reviewers. BMJ (2010) 3.38
Predicting 15-year prostate cancer specific mortality after radical prostatectomy. J Urol (2011) 3.36
A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients. Ann Surg (2006) 3.34
Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis. Nat Genet (2012) 3.33
Relationship of physical activity vs body mass index with type 2 diabetes in women. JAMA (2004) 3.31
Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens. J Urol (2003) 3.27
Location, extent and number of positive surgical margins do not improve accuracy of predicting prostate cancer recurrence after radical prostatectomy. J Urol (2009) 3.24
Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. Circulation (2009) 3.23
Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg (2006) 3.23
American Society of Clinical Oncology perspective: Raising the bar for clinical trials by defining clinically meaningful outcomes. J Clin Oncol (2014) 3.20
Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma. Eur Urol (2012) 3.20
Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg (2008) 3.16
Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg (2003) 3.14
Validation of an atrial fibrillation risk algorithm in whites and African Americans. Arch Intern Med (2010) 3.05
Using relative utility curves to evaluate risk prediction. J R Stat Soc Ser A Stat Soc (2009) 3.04
Low annual caseloads of United States surgeons conducting radical prostatectomy. J Urol (2009) 3.04
Net reclassification improvement: computation, interpretation, and controversies: a literature review and clinician's guide. Ann Intern Med (2014) 3.00
Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram. Ann Surg (2010) 2.99
Variations among high volume surgeons in the rate of complications after radical prostatectomy: further evidence that technique matters. J Urol (2005) 2.98
The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women's health study). J Am Coll Cardiol (2010) 2.96
Intakes of calcium and vitamin D and breast cancer risk in women. Arch Intern Med (2007) 2.95
Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50. Cancer (2010) 2.90
Body mass index and the risk of stroke in men. Arch Intern Med (2002) 2.90
The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative Group. Clin Cancer Res (2010) 2.87
Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg (2004) 2.86
Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg (2004) 2.84
An updated catalog of prostate cancer predictive tools. Cancer (2008) 2.82
C-reactive protein levels are not associated with increased risk for colorectal cancer in women. Ann Intern Med (2005) 2.79
Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy. Cancer (2005) 2.78
Prospective study of body mass index and risk of stroke in apparently healthy women. Circulation (2005) 2.73